Thursday, 27 June 2013

Novel Candidate Vaccine For Respiratory Syncytial Virus

Scientists in the US have developed a novel vaccination method that uses tiny gold particles to mimic a virus and carry specific proteins to the body's specialist immune cells. The technique differs from the traditional approach of using dead or inactive viruses as a vaccine and was demonstrated in the lab using a specific protein that sits on the surface of the respiratory syncytial virus (RSV). The results have been published in IOP Publishing's journal Nanotechnology by a team of researchers from Vanderbilt University... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment